Dialysis Access Justice, Equity, Diversity, Inclusion (DA-JEDI) Program.
透析获取正义、公平、多样性、包容性 (DA-JEDI) 计划。
基本信息
- 批准号:10661149
- 负责人:
- 金额:$ 11.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvisory CommitteesAmericanAreaBlack raceBlood VesselsCareer ChoiceCaringChildClinicClinicalCommunitiesDevelopmentDialysis procedureDisciplineEcosystemEnsureEntrepreneurshipEquityEthnic OriginEvaluationExposure toFeedbackFosteringFutureGenderGeographyGoalsGrantHealthHealth ProfessionalHealth Services AccessibilityHealthcareHispanicIndigenousIndividualInequityJusticeKidneyKidney DiseasesLeadershipLifeLinkMedicineMentorsMentorshipMinority GroupsNative Hawaiian or Other Pacific IslanderNephrologyNursesOutcomeParticipantPathway interactionsPatientsPeritoneal DialysisPersonsPharmacistsPhysiciansPoliciesPopulationPrevalenceProcessRaceResearchSocietiesTrainingTraining ProgramsUnited StatesWorkWorkforce DevelopmentWritingcandidate identificationcareercareer developmentcohortcourse developmentearly-career facultyequity, diversity, and inclusionhealth care disparityimprovedinnovationleadership developmentmeetingsmemberpatient orientedpeerpeer coachingpostersprogramsrecruitresponseskill acquisitionskills trainingsymposiumsynergismtraining opportunityvirtual
项目摘要
ABSTRACT
ASN is the largest nephrology society in the world with more than 21,000 members and a longstanding
commitment to justice, equity, diversity, and inclusion. Within kidney disease there is a great need for equity in
dialysis access (DA). We plan to significantly expand our DEI footprint in this area through the Dialysis Access-
Justice, Equity, Diversity and Inclusion program (DA-JEDI) by recruiting a cohort of fellows/early-career faculty
who identify as underrepresented in medicine (URM). These individuals would then be exposed to a unique
blend of mentorship, leadership, and skill development courses, with a strong DA focus, that will set them on a
pathway to become champions for equitable, patient-centered DA care, and also future leaders in ASN and the
broader dialysis access and kidney community. We will achieve these goals through four specific aims.
In Specific Aim 1 we will recruit a cohort of participants who identify as URM into DA-JEDI. In Specific Aim 2 we
will provide individualized didactic and experiential skills training through ASN initiatives, through the participants
CTSA, or though DA-JEDI’s own CTSA links. This will include an annual DA-JEDI Symposium. In Specific Aim
3, we will foster unique multi-faceted mentorship opportunities, and finally in Specific Aim 4 we will focus on the
creation of an alumni network, promote networking opportunities and develop an interactive evaluation process
with a strong feedback loop.
Putting it all together, we strongly believe that growing our DA-JEDI participants into future leaders for ASN, the
kidney community, and the DA community, will allow us to better serve our patients, who deserve justice, equity,
diversity, and inclusion in both DA and kidney care.
抽象的
ASN 是世界上最大的肾脏病学会,拥有超过 21,000 名会员,历史悠久
对正义、公平、多样性和包容性的承诺在肾脏疾病领域非常需要公平。
我们计划通过透析通路显着扩大我们在该领域的 DEI 足迹。
正义、公平、多元化和包容性计划(DA-JEDI),招募一批研究员/早期职业教员
然后,这些人将接触到独特的医学领域(URM)。
融合了指导、领导力和技能发展课程,并以 DA 为重点,这将使他们能够
成为公平、以患者为中心的 DA 护理倡导者以及 ASN 和 DA 未来领导者的途径
我们将通过四个具体目标来实现这些目标。
在具体目标 1 中,我们将招募一批被认定为 URM 的参与者进入 DA-JEDI。在具体目标 2 中,我们将招募一批参与者。
将通过 ASN 计划、通过参与者提供个性化的教学和体验技能培训
CTSA,或通过 DA-JEDI 自己的 CTSA 链接,这将包括年度 DA-JEDI 研讨会。
3、我们将培养独特的多方面指导机会,最后在具体目标 4 中,我们将重点关注
创建校友网络,促进交流机会并制定互动评估流程
具有强大的反馈循环。
总而言之,我们坚信,将我们的 DA-JEDI 参与者培养成为 ASN 的未来领导者,
肾脏社区和 DA 社区将使我们能够更好地为患者服务,他们应该得到正义、公平、
DA 和肾脏护理的多样性和包容性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tod Ramses Ibrahim其他文献
Tod Ramses Ibrahim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tod Ramses Ibrahim', 18)}}的其他基金
Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.
肾脏健康倡议是美国肾脏病学会、美国食品和药物管理局以及肾脏界之间的公私合作伙伴关系。
- 批准号:
10687995 - 财政年份:2014
- 资助金额:
$ 11.15万 - 项目类别:
Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.
肾脏健康倡议是美国肾脏病学会、美国食品和药物管理局以及肾脏界之间的公私合作伙伴关系。
- 批准号:
10449098 - 财政年份:2014
- 资助金额:
$ 11.15万 - 项目类别:
Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.
肾脏健康倡议是美国肾脏病学会、美国食品和药物管理局以及肾脏界之间的公私合作伙伴关系。
- 批准号:
10238797 - 财政年份:2014
- 资助金额:
$ 11.15万 - 项目类别:
相似海外基金
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 11.15万 - 项目类别:
Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
- 批准号:
10664134 - 财政年份:2023
- 资助金额:
$ 11.15万 - 项目类别:
Mayo Advancing Research Equity in ADRD Study in Jacksonville(MAREAS-Jax)
梅奥在杰克逊维尔推进 ADRD 研究中的研究公平性 (MAREAS-Jax)
- 批准号:
10729787 - 财政年份:2023
- 资助金额:
$ 11.15万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 11.15万 - 项目类别: